Fudulu Daniel Paul, Dorobantu Dan Mihai, Azar Sharabiani Mansour Taghavi, Angelini Gianni Davide, Caputo Massimo, Parry Andrew John, Stoica Serban Constantin
University Hospitals Bristol NHS Trust , Bristol , UK.
Imperial College , London , UK.
Open Heart. 2015 Sep 4;2(1):e000277. doi: 10.1136/openhrt-2015-000277. eCollection 2015.
Anomalous coronary artery from the pulmonary artery (ACAPA) is a very rare congenital anomaly that often occurs during infancy. Patients can present in a critical condition.
We analysed procedure-related data from a national audit database for the period 2000-2013.
A total of 120 patients <1 year had repair of isolated ACAPA using a coronary transfer or the tunnel (Takeuchi) operation. Seven patients (6.8%) required a mitral valve procedure at index and eight patients (7.8%) had a mitral valve repair/replacement during follow-up, including mitral reoperations. Follow-up data (>30 days) were available in 102 patients and the mean follow-up time was 4.7 years. The 30-day overall mortality was 1.9%, higher for neonates (16.7% vs 1%, p=0.1) and after postoperative extracorporeal membrane oxygenation (ECMO) (20% vs 1%, p=0.09). At 10 years the survival estimate is 95.1%, freedom from coronary and mitral reintervention being 95.9% and 91.2%, respectively. Use of postoperative ECMO was a risk factor for long-term mortality (p<0.001). Risk factors for coronary reintervention were age under 30 days (p=0.06) and the need for postoperative ECMO (p=0.02). Age under 30 days (p=0.002) was a risk factor for mitral reintervention.
To our knowledge this is the largest series to date. These preliminary national results show that early outcomes are good and medium-term attrition acceptable. Poor outcomes are correlated with early presentation, also with the need for postoperative circulatory support.
起源于肺动脉的异常冠状动脉(ACAPA)是一种非常罕见的先天性异常,常发生于婴儿期。患者可能以危急状态就诊。
我们分析了2000 - 2013年期间国家审计数据库中与手术相关的数据。
共有120例1岁以下患者接受了单独ACAPA修复术,采用冠状动脉移植或隧道(竹内)手术。7例患者(6.8%)在初次手术时需要进行二尖瓣手术,8例患者(7.8%)在随访期间进行了二尖瓣修复/置换,包括二尖瓣再次手术。102例患者有超过30天的随访数据,平均随访时间为4.7年。30天总死亡率为1.9%,新生儿的死亡率更高(16.7%对1%,p = 0.1),术后接受体外膜肺氧合(ECMO)的患者死亡率也更高(20%对1%,p = 0.09)。10年时生存率估计为95.1%,无冠状动脉和二尖瓣再次干预的比例分别为95.9%和91.2%。术后使用ECMO是长期死亡率的危险因素(p < 0.001)。冠状动脉再次干预的危险因素是年龄小于30天(p = 0.06)和术后需要ECMO(p = 0.02)。年龄小于30天(p = 0.002)是二尖瓣再次干预的危险因素。
据我们所知,这是迄今为止最大的系列研究。这些初步的全国性结果表明早期结果良好,中期损耗可接受。不良结果与早期就诊以及术后循环支持的需求有关。